The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Auteurs principaux: | , , , , , , |
|---|---|
| Autres auteurs: | |
| Format: | Conference item |
| Langue: | English |
| Publié: |
Elsevier
2020
|
| Résumé: |
|---|